Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03824041 · ClinicalTrials.gov registry record · NA

Effects of Aronia Berries on Vascular Endothelial Function and the Gut Microbiota in Middle-Aged/Older Adults

A NA study of Aging and Endothelial Dysfunction, sponsored by Colorado State University.

Completed
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT03824041: Completed NA study of Aging and Endothelial Dysfunction, sponsored by Colorado State University.

NCT03824041 is a NA study of Aging and Endothelial Dysfunction that has completed, run by Colorado State University. The registered enrollment target is 24 participants, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03824041, a NA study of Aging and Endothelial Dysfunction, has completed, sponsored by Colorado State University.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

Aging is the primary risk factor for cardiovascular disease (CVD) largely due to vascular endothelial dysfunction, a major initial step in the development of atherosclerosis. Endothelial dysfunction is characterized by impaired endothelium-dependent dilation and is primarily caused by reduced nitric oxide bioavailability secondary to oxidative stress and inflammation. Interventions that improve endothelial dysfunction are important for improving endothelial function and reducing CVD risk in this high-risk population. Aronia melanocarpa, commonly known as aronia berries or chokeberries, are rich in polyphenols such as anthocyanins, proanthocyanidins, and phenolic acids. These compounds, and derivatives resulting from gut microbial and phase II metabolism, have been shown to attenuate oxidative stress and inflammation, and to improve endothelial function. Aronia berries and other berries have been shown in numerous studies to have diverse cardiometabolic health effects including modulation of endothelial function, arterial stiffness, blood pressure, oxidative stress, and inflammation. In addition, berries, dietary fiber, polyphenols have been shown to exert positive effects on the gut microbiota, which may mediate improvements in cardiovascular health. Recently, we have demonstrated that modulation of the gut microbiota is associated with improvements in vascular dysfunction. The primary goal of the currently proposed research is to assess the efficacy and dose-dependent response of an aronia full spectrum dietary supplement to improve endothelial function in middle-aged/older men and postmenopausal women. A secondary goal is to determine whether aronia full spectrum modulation of the gut microbiota is associated with improvements in endothelial function. Other functional and biochemical measures of cardiovascular health, oxidative stress, inflammation, and polyphenol metabolism will be assessed.

Primary Outcome

Determine the effects on RHI measured by EndoPAT

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Aronia full spectrum - half dose
  • DIETARY_SUPPLEMENT Aronia full spectrum - full dose

Study Locations (1)

Colorado

  • Department of Food Science and Human Nutrition, Colorado State University - Fort Collins

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2019-02-11
Est. Completion 2021-07-26
Phase NA
Colorado State University

94 total trials

What the finished NCT03824041 record still lists

NCT03824041 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Aging appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT03824041 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT03824041 about?

NCT03824041 is a clinical study titled "Effects of Aronia Berries on Vascular Endothelial Function and the Gut Microbiota in Middle-Aged/Older Adults". Aging is the primary risk factor for cardiovascular disease (CVD) largely due to vascular endothelial dysfunction, a major initial step in the development of atherosclerosis. Endothelial dysfunction is characterized by impaired endothelium-dependent dilation and is primarily caused by reduced nitric...

What is the current status of trial NCT03824041?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2019-02-11. Estimated completion is 2021-07-26.

What conditions does trial NCT03824041 study?

This clinical trial studies the following conditions: Aging, Endothelial Dysfunction.

What interventions are being tested in trial NCT03824041?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Aronia full spectrum - half dose (DIETARY_SUPPLEMENT), Aronia full spectrum - full dose (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03824041?

This trial is sponsored by Colorado State University, which has 94 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03824041 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03824041's enrollment target sits among peer trials

24 214th of 262 higher than 40 of 262 other Aging trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03824041, the US trial registry maintained by the National Library of Medicine. NCT03824041 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.